The Clinical Benefits Continue to Build While GLP-1 therapies initially gained attention for weight loss, emerging research suggests the benefits may extend well beyond the scale
Interestingly, the group reported tolerance with repeated dosing that was independent of exposure levels
After four weeks, the dose is increased to 5 mg weekly, with subsequent escalations every four weeks (to 7.5 mg, 10 mg, 12.5 mg, and potentially 15 mg) based on glycaemic response and tolerability
That is also why our clinically supervised approach to physician-guided peptide therapy focuses on the body's own repair pathways rather than masking symptoms
A 2024 study used induced neurons created from fibroblasts donated by older adults
It helps ensure the drugs are prescribed judiciously, aligning with the individuals medical needs and overall treatment plan